Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-17 Gift | 2024-07-18 4:06 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director | 54,027 | $0 | 0 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:25 pm | N/A 2034-06-11 | Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director | 25,600 | $0 | 25,600 (Direct) | View |
| 2024-06-03 Exercise | 2024-06-04 6:48 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director | 20,500 | $3.75 | 53,700 (Direct) | View |
| 2024-06-03 Exercise | 2024-06-04 6:48 pm | N/A 2032-06-16 | Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director | 20,500 | $0 | 53,700 (Direct) | View |
| 2024-05-20 Option Award | 2024-05-20 7:26 pm | N/A 2034-05-19 | Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2024-04-08 Option Award | 2024-04-10 8:39 pm | N/A 2034-04-08 | Enliven Therapeutics Inc. | ELVN | Kunkel Lori Anne Director | 37,882 | $0 | 37,882 (Direct) | View |
Ownership | 2024-04-10 8:37 pm | N/A N/A | Enliven Therapeutics Inc. | ELVN | Kunkel Lori Anne Director | 0 | $0 | 65,625 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-15 4:56 pm | N/A 2033-06-13 | Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director | 20,500 | $0 | 20,500 (Direct) | View |
| 2023-05-04 Option Award | 2023-05-04 7:56 pm | N/A 2033-05-03 | Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-17 8:23 pm | N/A 2032-06-16 | Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director | 53,700 | $0 | 53,700 (Direct) | View |
| 2022-05-05 Option Award | 2022-05-06 5:23 pm | N/A 2032-05-04 | Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2022-01-31 Option Award | 2022-01-31 5:33 pm | N/A 2032-01-30 | CURIS INC | CRIS | Kunkel Lori Anne Director | 85,000 | $0 | 85,000 (Direct) | View |
| 2021-06-16 Option Award | 2021-06-17 7:48 pm | N/A 2031-06-15 | Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director | 16,625 | $0 | 16,625 (Direct) | View |
| 2021-05-06 Option Award | 2021-05-24 7:49 pm | N/A 2031-05-05 | Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director | 17,500 | $0 | 17,500 (Direct) | View |
| 2021-01-28 Option Award | 2021-01-29 4:30 pm | N/A 2031-01-27 | CURIS INC | CRIS | Kunkel Lori Anne Director | 33,000 | $0 | 33,000 (Direct) | View |
Ownership | 2020-07-23 6:53 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director | 0 | $0 | 58,332 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-10 5:09 pm | N/A 2030-06-08 | Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director | 28,515 | $0 | 28,515 (Direct) | View |
Ownership | 2020-06-10 5:07 pm | N/A N/A | Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director | 0 | $0 | 0 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 5:10 pm | N/A 2030-03-01 | CURIS INC | CRIS | Kunkel Lori Anne Director | 180,000 | $0 | 180,000 (Direct) | View |